Bankers Lament Loss of Deal Code Names

Related Link: 

For young bankers, choosing code names for deals is an amusing diversion from financial modeling, but one deal-making powerhouse is putting an end to the name game.

Toys 'R' Us Loss Widens

Related Link: 

Toys 'R' Us posted a wider loss in its fiscal second-quarter as discounts took a toll on the bottom line, even as sales rose.

Malaysia Airlines to Shed 30% of Its Workforce

Related Link: 

The state fund that controls Malaysia Airlines announced the largest round of layoffs in the company's history, the centerpiece of a plan to revive a carrier battered by two recent air tragedies, as well as years of weak earnings.

MMX CEO Resigns

Related Link: 

The chief executive of Brazilian mining company MMX Mineração e Metálicos SA resigned as the company faces a cash squeeze and is trying to find partners or sell assets to stay afloat.

Regulators Seek More Information on Reynolds, Lorillard Deal

Related Link: 

Federal regulators have requested more information on Reynolds American's pending deals to buy Lorillard and divest certain brands to Imperial Tobacco Group.

Lufthansa Threatened With Expanded Strikes

Related Link: 

The pilots union said that it could widen industrial action in progress at its budget subsidiary Germanwings to the group's other airlines over if it doesn't come up with a new offer on retirement benefits.

Dongfeng Motor's Earnings Surge

Related Link: 

China's Dongfeng Motor Group reported a 54% rise in first-half net profit, thanks to sales gains in its joint ventures with Japanese and French car makers.

Hershey Unveils New Logo

Related Link: 

Hershey unveiled a new logo Friday in an effort to give the 120-year-old chocolate company a more modern look.

Telefónica Eyes Deal by Mid-2015

Related Link: 

Spanish telecommunications company Telefónica said it expects to complete the $9.82 billion acquisition of Vivendi's Brazilian unit, GVT, by mid-2015.

J&J, Bayer Aim to Expand Xarelto's Uses

Related Link: 

Johnson & Johnson and Bayer announced plans to launch clinical trials of the anticoagulant Xarelto against three new diseases in an ambitious bid to widen the market for a drug poised to exceed $1 billion in sales this year.

Syndicate content